Sarah Gilligan, who serves as Chief Supply Chain & Transformation Officer at Gap Inc. (NYSE:GAP), completed the sale of 69,912 shares of the company's common stock on March 23, 2026. The shares were sold at $25.00 apiece, bringing the total proceeds to $1.75 million. The transaction was executed pursuant to a Rule 10b5-1 trading plan that Gilligan adopted on June 6, 2025.
Following the disposition, Gilligan directly owns zero shares of Gap Inc. The sale represents a full exit of her direct holdings as disclosed in the transaction report.
Quarterly results and company metrics
Gap reported fourth-quarter results for fiscal 2025 that were in line with analysts' forecasts, posting earnings per share of $0.45 and revenue of $4.2 billion. Those numbers indicate the company met its publicly stated expectations for the quarter.
Separately, InvestingPro's assessment indicates Gap appears undervalued based on its Fair Value calculation. The firm assigns Gap a "GREAT" financial health score and notes the company has maintained dividend payments for 51 consecutive years.
Compensation plan updates
Gap has updated award agreements under its 2016 Long-Term Incentive Plan, introducing new versions for several categories of stock and performance awards. The changes are intended to govern the terms for future grants to eligible employees and directors.
Analyst view
TD Cowen reiterated a Buy rating on Gap with a price target of $32.00. In its commentary, the firm pointed to continued business momentum despite some fourth-quarter challenges. TD Cowen highlighted factors including merchandise execution, brand relevance, and marketing as contributors to consistent performance for both Old Navy and Gap brands.
What this filing and update show
The insider sale was processed under a prearranged trading plan adopted in mid-2025 and resulted in Gilligan holding no direct shares following the transaction. At the same time, Gap's quarterly financial results matched expectations and the company has refreshed the documentation that will govern future long-term incentive grants. Analyst support from TD Cowen and InvestingPro's valuation and health assessments provide additional context that some investors may use when assessing the company's position.
Where the public record is limited, this article reflects the information disclosed by the company and by the cited analysis.